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Implications for practice and research 
 Patient self-monitoring of disease activity can improve tight control of 
rheumatoid arthritis (RA). 
 Nurse-led care can be used in the monitoring and management of 
comorbidities associated with RA.  
 Further research should assess wider acceptability, as well as the clinical 
and cost-effectiveness of a patient self-monitoring approach. 
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Context  
Tight control’ of rheumatoid arthritis (RA) is defined as the frequent assessment 
of disease activity and subsequent adjustments in medication in order to keep 
inflammation at a low level or ultimately in remission. This ‘treat-to-target’ 
approach is the current gold standard in treating RA and is associated with 
better outcomes for people with the condition.  
The evidence of nurse-led care (NLC) effectiveness in RA management has 
been established in the UK, the Netherlands, Sweden, Denmark and Norway.1-5 
The COMEDRA trial in France, was the first large RCT to concurrently evaluate 
the efficacy of NLC and patient self-monitoring of disease activity using the 28-
joint Disease Activity Score (DAS28).  
Methods 
COMEDRA was an unblinded RCT comprising two active interventions carried 
out in a self-monitoring group and a nurse-led comorbidities group; each acting 
as control of the other. In the self-monitoring group, patients were taught to 
assess their own disease activity through a DAS28 score and report this to their 
rheumatologist; who used this information to adjust treatment in a treat-to-target 
approach. In the nurse-led comorbidities group, nurses systematically assessed 
presence/risk of the comorbidities associated with RA; and incorporated this into 
patient education and/or referral to a physician for action.  
 
Outcomes were assessed monthly, for 6 months, the primary outcomes being 
the percentage of patients who had their therapy adjusted as per treat-to-target 
approach and the number of measures taken to address comorbidities. 
Analyses were by intention-to-treat and mixed logistic-regression models were 
used to assess between-group differences. 
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Findings  
Overall, treatment escalation occurred more in the self-monitoring group (17.2% 
of patients), suggesting a tighter control of RA than in the nurse-led 
comorbidities group (10.9% of patients); OR (95%CI) 1.70 (1.17 to 2.19), 
p<0.001. The Nurse-led comorbidities group had more measures taken per 
patient, to address comorbidities (mean=4.54, SD=2.08) than the self-monitoring 
group (mean=2.65, SD=1.57); incidence rate ratio (95%CI) 1.78 (1.61 to 1.96), 
p<0.001.  
 
The results provide two key messages: (1) self-monitoring can enhance tight 
control of RA disease activity and (2) NLC can have the desired effect in 
managing comorbidities associated with RA.  
Commentary  
This was an explanatory RCT, assessing the efficacy of patient self-
assessment, which was not routine practice. While the results are welcome, 
their applicability to practice is limited. Also, due to the nature of this study, the 
clinicians and the patients (who were also outcome assessors) were not blinded; 
therefore the risk of performance and/or detection bias cannot be excluded.  
There is strong evidence to support the effectiveness of NLC in managing 
disease activity.2-5 The COMEDRA trial provided new evidence supporting self-
monitoring as a viable model in managing disease activity. Recently, a 
systematic review of European studies6 has shown that nurses are involved in 
assessing and managing comorbidities in different settings. It is plausible to 
expect that combining NLC with self-monitoring can enhance tight control of RA 
and the management of comorbidities; improving the overall long-term 
outcomes in people with RA. 
Further research is needed to evaluate the clinical and cost-effectiveness of 
self-monitoring approach before recommending a change in practice.  A wider 
acceptability of this intervention will also need to be tested in different 
settings/countries in order to ensure its implementation.   
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